190 related articles for article (PubMed ID: 19967781)
1. Impact of counterion on the chemical stability of crystalline salts of procaine.
Guerrieri P; Jarring K; Taylor LS
J Pharm Sci; 2010 Sep; 99(9):3719-30. PubMed ID: 19967781
[TBL] [Abstract][Full Text] [Related]
2. Analysis of relationships between solid-state properties, counterion, and developability of pharmaceutical salts.
Guerrieri P; Rumondor AC; Li T; Taylor LS
AAPS PharmSciTech; 2010 Sep; 11(3):1212-22. PubMed ID: 20680707
[TBL] [Abstract][Full Text] [Related]
3. Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs.
David SE; Timmins P; Conway BR
Drug Dev Ind Pharm; 2012 Jan; 38(1):93-103. PubMed ID: 22118222
[TBL] [Abstract][Full Text] [Related]
4. Salt Disproportionation in the Solid State: Role of Solubility and Counterion Volatility.
Thakral NK; Behme RJ; Aburub A; Peterson JA; Woods TA; Diseroad BA; Suryanarayanan R; Stephenson GA
Mol Pharm; 2016 Dec; 13(12):4141-4151. PubMed ID: 27766882
[TBL] [Abstract][Full Text] [Related]
5. Salt effects on an ion-molecule reaction--hydroxide-catalyzed hydrolysis of benzocaine.
Al-Maaieh A; Flanagan DR
Pharm Res; 2006 Mar; 23(3):589-94. PubMed ID: 16382278
[TBL] [Abstract][Full Text] [Related]
6. An investigation into the influence of counterion on the properties of some amorphous organic salts.
Towler CS; Li T; Wikström H; Remick DM; Sanchez-Felix MV; Taylor LS
Mol Pharm; 2008; 5(6):946-55. PubMed ID: 19434850
[TBL] [Abstract][Full Text] [Related]
7. The Selection of a Pharmaceutical Salt-The Effect of the Acidity of the Counterion on Its Solubility and Potential Biopharmaceutical Performance.
He Y; Orton E; Yang D
J Pharm Sci; 2018 Jan; 107(1):419-425. PubMed ID: 29107790
[TBL] [Abstract][Full Text] [Related]
8. Salt formation improved the properties of a candidate drug during early formulation development.
Sigfridsson K; Ahlqvist M; Lindsjö M; Paulsson S
Eur J Pharm Sci; 2018 Jul; 120():162-171. PubMed ID: 29730322
[TBL] [Abstract][Full Text] [Related]
9. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
10. Ion pair stabilization effects on a series of procaine structural analogs.
Malvezzi A; do Amaral AT
Eur J Pharm Sci; 2010 Dec; 41(5):631-5. PubMed ID: 20854904
[TBL] [Abstract][Full Text] [Related]
11. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
Dichiarante E; Curzi M; Giaffreda SL; Grepioni F; Maini L; Braga D
J Pharm Pharmacol; 2015 Jun; 67(6):823-9. PubMed ID: 25644936
[TBL] [Abstract][Full Text] [Related]
12. Early development evaluation of AZD2738, a substrate for the NK receptors.
Sigfridsson K; Ahlqvist M; Lindsjö M; Paulsson S
Drug Dev Ind Pharm; 2011 Jun; 37(6):719-26. PubMed ID: 21323487
[TBL] [Abstract][Full Text] [Related]
13. A case study where pharmaceutical salts were used to address the issue of low in vivo exposure.
Sigfridsson K; Ulvinge ML; Svensson L; Granath AK
Drug Dev Ind Pharm; 2019 Feb; 45(2):202-211. PubMed ID: 30256689
[TBL] [Abstract][Full Text] [Related]
14. The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions.
Hughey JR; Keen JM; Miller DA; Kolter K; Langley N; McGinity JW
Eur J Pharm Sci; 2013 Mar; 48(4-5):758-66. PubMed ID: 23348153
[TBL] [Abstract][Full Text] [Related]
15. Salt formation to improve drug solubility.
Serajuddin AT
Adv Drug Deliv Rev; 2007 Jul; 59(7):603-16. PubMed ID: 17619064
[TBL] [Abstract][Full Text] [Related]
16. Compound selection for development - is salt formation the ultimate answer? Experiences with an extended concept of the "100mg approach".
Korn C; Balbach S
Eur J Pharm Sci; 2014 Jun; 57():257-63. PubMed ID: 24036162
[TBL] [Abstract][Full Text] [Related]
17. The improvement of aqueous chemical stability of a model basic drug by ion pairing with acid groups of polyelectrolytes.
Jimenez-Kairuz AF; Allemandi DA; Manzo RH
Int J Pharm; 2004 Jan; 269(1):149-56. PubMed ID: 14698586
[TBL] [Abstract][Full Text] [Related]
18. A new cocrystal and salts of itraconazole: comparison of solid-state properties, stability and dissolution behavior.
Shevchenko A; Bimbo LM; Miroshnyk I; Haarala J; Jelínková K; Syrjänen K; van Veen B; Kiesvaara J; Santos HA; Yliruusi J
Int J Pharm; 2012 Oct; 436(1-2):403-9. PubMed ID: 22750429
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical salts of ciprofloxacin with dicarboxylic acids.
Surov AO; Manin AN; Voronin AP; Drozd KV; Simagina AA; Churakov AV; Perlovich GL
Eur J Pharm Sci; 2015 Sep; 77():112-21. PubMed ID: 26066411
[TBL] [Abstract][Full Text] [Related]
20. Disproportionation of a crystalline citrate salt of a developmental pharmaceutical compound: characterization of the kinetics using pH monitoring and online Raman spectroscopy plus quantitation of the crystalline free base form in binary physical mixtures using FT-Raman, XRPD and DSC.
Skrdla PJ; Zhang D
J Pharm Biomed Anal; 2014 Mar; 90():186-91. PubMed ID: 24378612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]